KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Return on Invested Capital (2021 - 2025)

Rigel Pharmaceuticals has reported Return on Invested Capital over the past 4 years, most recently at 0.01% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 13.0% year-over-year to 0.01%; the TTM value through Dec 2025 reached 0.01%, up 13.0%, while the annual FY2025 figure was 0.02%, 6.0% up from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.01% at Rigel Pharmaceuticals, up from 0.01% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.07% in Q3 2022 and troughed at 0.51% in Q2 2022.
  • A 4-year average of 0.05% and a median of 0.0% in 2021 define the central range for Return on Invested Capital.
  • Biggest five-year swings in Return on Invested Capital: tumbled -51bps in 2022 and later increased 13bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.0% in 2021, then surged by 2178bps to 0.07% in 2022, then tumbled by -268bps to 0.11% in 2024, then skyrocketed by 112bps to 0.01% in 2025.
  • Business Quant data shows Return on Invested Capital for RIGL at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.